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Periodontitis is a polymicrobial biofilm-mediated disease of the oral cavity and is a chronic inflammatory condition of the periodontium, leading to the damage of structural tooth support, resorption of bone, and eventually tooth loss ([@bib18]). The microbial etiology of periodontitis is defined by oral biofilm, also called dental plaque, in which resides an interdependent microbial community containing numerous bacterial species ([@bib21]). A typical dental biofilm begins with the formation of the salivary acquired pellicle, which is a result of the selective adsorption of salivary components, such as statherin, histatin, acidic proline-rich proteins, albumin, mucins, and α-amylase onto the tooth surface ([@bib10]; [@bib25]). Early colonizers then directly attach to various molecules of the acquired pellicle *via* the selective adhesin-receptor binding and form an initial dental plaque ([@bib10]). Representative bacteria that constitute the initial biofilm are streptococci, which are mostly commensal/non-periodontopathogenic bacteria and makeup over 80% of the early biofilm inhabitants ([@bib10]), quickly followed by *Actinomyces, Gemella, Neisseria*, and *Veillonella*. As plaque matures, the composition of the biofilm changes. With the introduction and an increasing number of anaerobic bacteria such as *Porphyromonas, Fusobacterium, Prevotella, Veillonella*, and *Capnocytophaga*, the diversity of the species constituting the plaque increases ([@bib25]). Several experimental studies suggested that periodontal diseases are generally associated with Gram-negative anaerobic bacteria, such as *Aggregatibacter actinomycetemcomitans, Tannerella forsythia, Prevotella* spp., *Fusobacterium* spp. and *Porphyromonas gingivalis* ([@bib24]; [@bib23]; [@bib4]; [@bib5]; [@bib22]). However, it is now widely accepted that not any one of these bacterial species alone, but a concerted interaction of these members can cause the destructive events involved in the periodontal disease progression ([@bib12]; [@bib3]; [@bib7]; [@bib16]).

Polyphosphate (polyP) is an inorganic polymer composed of three to several hundred orthophosphate residues linked by phosphoanhydride bonds ([@bib9]). The type of polyP varies depending on the length of the phosphate chain constituting it, for example, polyP3, polyP5, polyP15, polyP45, and so on, even up to polyP chains of many hundreds of phosphate residues. The Food and Drug Administration (FDA) has listed sodium pyro-, tri-, and hexametaphosphates as the Generally Recognized as Safe (GRAS) food additives. PolyP is often added to dairy and meat products for water binding, ion exchange, emulsification, and antioxidation ([@bib2]). In addition, due to the antimicrobial effects against various Gram-positive bacteria and fungi ([@bib8]), thereby suppressing food spoilage, polyP has drawn the attention of food industry.

Recently, it was reported that some Gram-negative anaerobic periodontal pathogens were highly sensitive to polyP. The minimum inhibitory concentrations (MICs) of polyP against *P. gingivalis* W83 and *P. intermedia* ATCC 49046 ranged from 0.06 to 0.075%, which were much lower than those previously reported for Gram-positive bacteria ([@bib15]; [@bib6]). Bacterial species rarely inhabit infection sites alone instead reside in diverse, multispecies communities ([@bib20]). Hence, to adequately assess the potential of polyP as a controlling agent against oral pathogenic bacteria, it is necessary to ascertain the effect of polyP not only on an individual microbial species but also on the consortium of mixed-species. In the present study, we investigated the effects of sodium tripolyphosphate (polyP3, Na~5~P~3~O~10~), listed as a GRAS, on four major oral bacterial species, including commensal and pathogenic bacteria. We also evaluated the antimicrobial effect of polyP3 against the mixed-species consortium consisting of the four bacterial species.
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**Bacterial strains and culture condition.** We used *S. gordonii* G9B, *F. nucleatum* ATCC 23726, *P. gingivalis* ATCC 53977 (previously designated A7A1-28), and *P. intermedia* ATCC 49046. Each bacterial strain was grown either in Brucella agar (Becton, Dickinson and Company, Sparks, MD, USA) supplemented with 5% sheep blood, 5 µg/ml hemin (Sigma Chemical Co., St. Louis, MO, USA) and 1 μg/ml vitamin K~1~ (Sigma), or in Brucella broth (Becton, Dickinson and Company) supplemented with 5 µg/ml hemin and 1 μg/ml vitamin K~1~ (B-HK). The bacterial culture was incubated at 37°C under anaerobic conditions (85% N~2~, 10% H~2~ and 5% CO~2~).

**MIC determination and individual bacterial growth.** PolyP with chain length 3 (polyP3, Na~5~P~3~O~10~, Sigma) was dissolved in distilled water to 10% (wt/vol) and sterilized using a 0.22-µm filter. The MIC of polyP3 against the individual bacterial species was determined by agar dilution method according to CLSI guidelines ([@bib1]). Briefly, optical density at 600 nm (OD~600~) of each bacterial suspension was adjusted, then the suspension was inoculated at a cell density of approximately 10^5^ to 10^6^ cells/spot on Brucella blood agar plates containing polyP3 (final concentrations of 0.015--0.2%). The number of the inoculated bacterial cells was confirmed by serial dilution and colony forming unit (CFU) count. All inoculated plates were incubated at 37°C for 72 h. The MIC was defined as the lowest concentration that inhibited the bacterial growth on the plate. To evaluate the effect of polyP3 on the growth of the bacteria at a high inoculum density, each bacterial strain cultured to exponential phase was adjusted to approximately 10^8^ cells/ml in B-HK, then exposed to polyP3 at various concentrations. The bacterial growth was measured by reading OD~600~ after 24 hours.

**Total growth and biofilm formation of mixed bacterial culture.** We also investigated the effect of polyP3 on the total growth and biofilm formation of the four bacterial species in a mixed culture. In preliminary studies, we observed that a mixed-species biofilm with relatively uniform distribution of four strains can be developed by inoculating *S. gordonii, F. nucleatum, P. gingivalis* and *P. intermedia* cells at a ratio of 1 : 1 : 100 : 100. We estimated the number of individual bacterial cells by measuring and adjusting of OD~600~ of each culture, then mixed so that the cell number ratio was as above. The mixed bacterial suspension was dispensed in triplicate into wells (500 μl/well) of a 24-well plate containing B-HK (500 μl) supplemented with polyP3 at various concentrations. The final bacterial suspension was approximately 10^8^ to 10^9^ cells/ml. Two identical 24-well plates were prepared for each of three independent experiments and cultured for 72 h under the same environment as the culture condition for single bacterial species, without agitation and media replenishment. To assess the total growth (planktonic and biofilm bacterial growth), the biofilm bacterial cells were dispersed and mixed thoroughly with planktonic bacterial cells, and OD~600~ of the suspension was measured ([@bib14], [@bib13]). The suspension was diluted 2 to 10 times, and OD~600~ of the diluted suspension was also measured. The amount of biofilm formed by the mixed bacterial species was measured using the other plate. The planktonic bacterial cells and the spent media were removed, and the biofilm formed in the wells was washed twice with physiological saline, then stained with 0.1% crystal violet for 10 min. The plate was washed three times with physiological saline and air dried. Then, 500 µl of 95% ethanol was added to release the crystal violet from the biofilm, and the OD~600~ was recorded.

**Scanning electron microscopy (SEM).** Mixed species biofilms were developed as described above, then washed, dried, fixed in ethanol and dried again, as described previously ([@bib6]). The biofilm samples were coated with gold using a sputter-coater (IB-3, Eiko, Tokyo, Japan) and then observed at 10 kV under a scanning electron microscope (Model S-4700; Hitachi High Technologies America. Inc., Pleasanton, CA, USA).
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**PolyP3 effectively inhibits the major oral pathogenic bacteria.** It has been reported that polyP has antibacterial activity against various Gram-positive bacteria (such as *Staphylococcus aureus, Bacillus cereus, Listeria monocytogenes*, and mutans streptococci) at the concentrations between 0.1 and 0.5%, although it varies depending on the bacterial strain, inoculum density and culture medium ([@bib17]; [@bib19]; [@bib26]; [@bib11]). In the present study, the growth of a Gram-positive bacterium *S. gordonii* was not inhibited by polyP3 (up to 0.2%) on an agar plate (Fig. [1](#fig1){ref-type="fig"}). Meanwhile, in liquid medium, the bacterial growth was slightly but significantly reduced by polyP3 in the range of 0.01--0.1%, and almost completely inhibited at concentrations ≥ 0.2% (Fig. [2](#fig2){ref-type="fig"}). Compared to *S. gordonii*, the three pathogenic bacteria: *F. nucleatum* ATCC 23726, *P. gingivalis* ATCC 53977, and *P. intermedia* ATCC49046 were more susceptible to polyP3. As shown in Fig. [1](#fig1){ref-type="fig"}, the MICs of polyP3 against the bacteria were 0.1, 0.075 and 0.075 %, respectively, as determined by the agar dilution method. Notably, despite the bacterial inoculum concentration approximately 1000-fold higher than that used for the MIC determination, polyP3 still exerted a strong antibacterial activity in liquid medium (BH-K) (Fig. [2](#fig2){ref-type="fig"}). The difference between the antibacterial effects of polyP3 observed in the agar and broth dilution methods is likely due to the fact that the MIC determined by the agar dilution method was the concentration at which the bacterial growth was completely inhibited bacteriostatically and/or bactericidally. MIC determined by agar dilution method is not affected by whether an antibacterial agent is bactericidal or bacteriostatic. In contrast, if the bacterial cells were killed by polyP3 in the liquid medium, they may have been lysed, lowering the OD~600~ values. It is also possible that the liquid medium enhanced the contact of polyP3 with individual bacterial cells, resulting in an excellent antimicrobial effect of polyP3 in the liquid medium.

![MIC determination of polyP3 by the agar dilution method. The bacterial cells were spot-inoculated (approximately 10^5^ to 10^6^ cells/spot) onto Brucella blood agar plates containing polyP3 at various concentrations and incubated at 37°C for 3 days anaerobically. The MIC was defined as the lowest concentration that inhibited the bacterial growth on the plate. The results for *P. intermedia* ATCC 49046 are the same as those reported in our previous study ([@bib6]).](pjm-68-2-263-g001){#fig1}

![Effect of polyP3 on the growth of the bacteria at a high inoculum density. Each bacterial strain cultured to exponential phase was adjusted to approximately 10^8^ cells/ml in B-HK, then exposed to polyP3 at various concentrations. The bacterial growth was measured by reading optical density at 600 nm (OD~600~) after the 24-hour incubation. Data are means ± SDs from two independent experiments performed in triplicate. One-way ANOVA with Tukey's post-hoc tests *p* \< 0.001, versus control (0% polyP3).](pjm-68-2-263-g002){#fig2}

**PolyP3 selectively inhibits the major oral pathogenic bacteria in the mixed-culture.** When the four bacterial species were co-cultured, the total growth, as well as the biofilm formation, was enhanced, probably due to their symbiotic relationship. As shown in Fig. [3A](#fig3){ref-type="fig"}, the total growth and biofilm formation of the mixed species were significantly inhibited by polyP3 (≥ 0.05%). In the morphological analysis by SEM (Fig. [3B](#fig3){ref-type="fig"}), the control biofilm (not exposed to polyP3) showed a multilayered structure consisting of spherical-shaped *S. gordonii*, spindle-shaped *F. nucleatum*, along with rod-shaped bacterial cells presumed to be *P. gingivalis* and *P. intermedia*. On the other hand, in the biofilms exposed to polyP3 (≥ 0.05%), spindle- and rod-shaped cells decreased. The biofilm exposed to 0.1% polyP3 was a simple structure composed of only streptococci, indicating that polyP3 still exerts stronger antimicrobial effects against the three Gram-negative pathogenic bacteria than *S. gordonii* in the mixed culture.

![Effect of polyP3 on the growth and biofilm formation of the four bacterial species in a mixed culture. (A) To assess the total growth (planktonic and biofilm bacterial growth), the biofilm bacterial cells were dispersed, mixed thoroughly with planktonic bacterial cells, and OD~600~ of the suspension was measured. The suspension was diluted 2 to 10 times, and OD~600~ of the diluted suspension was also measured. The amount of biofilm formed by the mixed bacterial species was quantitated by crystal violet staining. Readings were expressed as mean %OD~600~ (%OD~600~ = OD~600~ ∕ mean OD~600~ of control × 100). One-way ANOVA with Tukey's post-hoc tests *p* \< 0.001, versus control (0% polyP3). (B) SEM images of the biofilms at a magnification of 20 000 × (left) and 100 000 × (right).](pjm-68-2-263-g003){#fig3}

There are a vast number of U.S. patents for the use of polyP3 in oral care preparations. Although STPP has been included in oral care products for stain removal and brightening of the enamel, antibacterial effect of polyP3 apparently has not drawn the attention of the dentistry academy and the oral health industry. Here, we are inclined to emphasize the powerful potential of polyP3 with antibacterial activity, which is required for an ideal oral hygiene product. PolyP3 can be an effective antibacterial agent to control the major oral pathogenic bacteria *P. intermedia, P. gingivalis*, and *F. nucleatum*. The ability of polyP3 to selectively inhibit pathogens and maintain the proportion of commensal bacteria may be effective in preventing oral diseases caused by these pathogenic bacteria.
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